🇺🇸 FDA
Patent

US 6596275

Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions

expired A61KA61K38/00A61K39/0008

Quick answer

US patent 6596275 (Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions) held by I.D.M. Immuno-Designed Molecules expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
I.D.M. Immuno-Designed Molecules
Grant date
Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K39/0008, A61K40/17, A61K40/22